Relapsed CD22-positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB05889 | Inotuzumab ozogamicin | An antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB05889 | Inotuzumab ozogamicin | P-glycoprotein 1 | transporter |
| DB05889 | Inotuzumab ozogamicin | B-cell receptor CD22 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|